Osteocyte apoptosis regulates osteoclast precursor adhesion via osteocytic IL-6 secretion and endothelial ICAM-1 expression

Bone

Volumn 50, Issue 1, 2012, Pages 104-110

  Cheung, Wing Yee ^a   Simmons, Craig A ^a,b   You, Lidan ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Apoptosis; ICAM 1; IL 6; Osteoclast precursor recruitment; Osteocyte

Indexed keywords

BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL ACTIVATION; CELL ADHESION; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE RELEASE; EMBRYO; ENDOTHELIUM CELL; FLOW CYTOMETRY; MOUSE; NONHUMAN; OSTEOCYTE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; STEM CELL; VASCULAR ENDOTHELIUM;

ANIMALS; APOPTOSIS; CELL ADHESION; CULTURE MEDIA, CONDITIONED; ENDOTHELIAL CELLS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-6; MICE; OSTEOCLASTS; OSTEOCYTES; RECEPTORS, INTERLEUKIN-6; STEM CELLS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 80054976334     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2011.09.052     Document Type: Article

References (45)

1. Aguirre J.I., Plotkin L.I., Stewart S.A., Weinstein R.S., Parfitt A.M., Manolagas S.C., et al. Osteocyte apoptosis is induced by weightlessness in mice and precedes osteoclast recruitment and bone loss. J Bone Miner Res 2006, 21:605-615.
2. Cardoso L., Herman B.C., Verborgt O., Laudier D., Majeska R.J., Schaffler M.B. Osteocyte apoptosis controls activation of intracortical resorption in response to bone fatigue. J Bone Miner Res 2009, 24:597-605.
3. Verborgt O., Tatton N.A., Majeska R.J., Schaffler M.B. Spatial distribution of Bax and Bcl-2 in osteocytes after bone fatigue: complementary roles in bone remodeling regulation?. J Bone Miner Res 2002, 17:907-914.
4. Verborgt O., Gibson G.J., Schaffler M.B. Loss of osteocyte integrity in association with microdamage and bone remodeling after fatigue in vivo. J Bone Miner Res 2000, 15:60-67.
5. Scheven B.A., Wassenaar A.M., Kawilarang-de Haas E.W., Nijweide P.J. Comparison of direct and indirect radiation effects on osteoclast formation from progenitor cells derived from different hemopoietic sources. Radiat Res 1987, 111:107-118.
6. Andersen T.L., Sondergaard T.E., Skorzynska K.E., Dagnaes-Hansen F., Plesner T.L., Hauge E.M., et al. A physical mechanism for coupling bone resorption and formation in adult human bone. Am J Pathol 2009, 174:239-247.
7. Cheung W.Y., Liu C., Tonelli-Zasarsky R.M., Simmons C.A., You L. Osteocyte apoptosis is mechanically regulated and induces angiogenesis in vitro. J Orthop Res 2011, 29:523-530.
8. McGowan N.W., Walker E.J., Macpherson H., Ralston S.H., Helfrich M.H. Cytokine-activated endothelium recruits osteoclast precursors. Endocrinology 2001, 142:1678-1681.
9. Kindle L., Rothe L., Kriss M., Osdoby P., Collin-Osdoby P. Human microvascular endothelial cell activation by IL-1 and TNF-alpha stimulates the adhesion and transendothelial migration of circulating human CD14+ monocytes that develop with RANKL into functional osteoclasts. J Bone Miner Res 2006, 21:193-206.
10. Hurst S.M., Wilkinson T.S., McLoughlin R.M., Jones S., Horiuchi S., Yamamoto N., et al. Il-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation. Immunity 2001, 14:705-714.
11. Ishimi Y., Miyaura C., Jin C.H., Akatsu T., Abe E., Nakamura Y., et al. IL-6 is produced by osteoblasts and induces bone resorption. J Immunol 1990, 145:3297-3303.
12. Chenoufi H.L., Diamant M., Rieneck K., Lund B., Stein G.S., Lian J.B. Increased mRNA expression and protein secretion of interleukin-6 in primary human osteoblasts differentiated in vitro from rheumatoid and osteoarthritic bone. J Cell Biochem 2001, 81:666-678.
13. Kwan Tat S., Padrines M., Theoleyre S., Heymann D., Fortun Y. IL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiology. Cytokine Growth Factor Rev 2004, 15:49-60.
14. Li Y., Backesjo C.M., Haldosen L.A., Lindgren U. IL-6 receptor expression and IL-6 effects change during osteoblast differentiation. Cytokine 2008, 43:165-173.
15. Franchimont N., Wertz S., Malaise M. Interleukin-6: an osteotropic factor influencing bone formation?. Bone 2005, 37:601-606.
16. Jilka R.L., Hangoc G., Girasole G., Passeri G., Williams D.C., Abrams J.S., et al. Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science 1992, 257:88-91.
17. Jones S.A., Horiuchi S., Topley N., Yamamoto N., Fuller G.M. The soluble interleukin 6 receptor: mechanisms of production and implications in disease. FASEB J 2001, 15:43-58.
18. Saito M., Yoshida K., Hibi M., Taga T., Kishimoto T. Molecular cloning of a murine IL-6 receptor-associated signal transducer, gp130, and its regulated expression in vivo. J Immunol 1992, 148:4066-4071.
19. Chalaris A., Rabe B., Paliga K., Lange H., Laskay T., Fielding C.A., et al. Apoptosis is a natural stimulus of IL6R shedding and contributes to the proinflammatory trans-signaling function of neutrophils. Blood 2007, 110:1748-1755.
20. Mullberg J., Schooltink H., Stoyan T., Gunther M., Graeve L., Buse G., et al. The soluble interleukin-6 receptor is generated by shedding. Eur J Immunol 1993, 23:473-480.
21. Lust J.A., Donovan K.A., Kline M.P., Greipp P.R., Kyle R.A., Maihle N.J. Isolation of an mRNA encoding a soluble form of the human interleukin-6 receptor. Cytokine 1992, 4:96-100.
22. Coletta I., Soldo L., Polentarutti N., Mancini F., Guglielmotti A., Pinza M., et al. Selective induction of MCP-1 in human mesangial cells by the IL-6/sIL-6R complex. Exp Nephrol 2000, 8:37-43.
23. Hashizume M., Hayakawa N., Suzuki M., Mihara M. IL-6/sIL-6R trans-signalling, but not TNF-alpha induced angiogenesis in a HUVEC and synovial cell co-culture system. Rheumatol Int 2009, 29:1449-1454.
24. Peake N.J., Khawaja K., Myers A., Nowell M.A., Jones S.A., Rowan A.D., et al. Interleukin-6 signalling in juvenile idiopathic arthritis is limited by proteolytically cleaved soluble interleukin-6 receptor. Rheumatology (Oxford) 2006, 45:1485-1489.
25. Modur V., Li Y., Zimmerman G.A., Prescott S.M., McIntyre T.M. Retrograde inflammatory signaling from neutrophils to endothelial cells by soluble interleukin-6 receptor alpha. J Clin Invest 1997, 100:2752-2756.
26. Franchimont N., Lambert C., Huynen P., Ribbens C., Relic B., Chariot A., et al. Interleukin-6 receptor shedding is enhanced by interleukin-1beta and tumor necrosis factor alpha and is partially mediated by tumor necrosis factor alpha-converting enzyme in osteoblast-like cells. Arthritis Rheum 2005, 52:84-93.
27. Romano M., Sironi M., Toniatti C., Polentarutti N., Fruscella P., Ghezzi P., et al. Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity 1997, 6:315-325.
28. Zahler S., Kupatt C., Becker B.F. Endothelial preconditioning by transient oxidative stress reduces inflammatory responses of cultured endothelial cells to TNF-alpha. FASEB J 2000, 14:555-564.
29. Voll R.E., Herrmann M., Roth E.A., Stach C., Kalden J.R., Girkontaite I. Immunosuppressive effects of apoptotic cells. Nature 1997, 390:350-351.
30. Fadok V.A., Bratton D.L., Konowal A., Freed P.W., Westcott J.Y., Henson P.M. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Invest 1998, 101:890-898.
31. Xu W., Roos A., Schlagwein N., Woltman A.M., Daha M.R., van Kooten C. IL-10-producing macrophages preferentially clear early apoptotic cells. Blood 2006, 107:4930-4937.
32. Amarilyo G., Verbovetski I., Atallah M., Grau A., Wiser G., Gil O., et al. iC3b-opsonized apoptotic cells mediate a distinct anti-inflammatory response and transcriptional NF-kappaB-dependent blockade. Eur J Immunol 2010, 40:699-709.
33. Sule S., Rosen A., Petri M., Akhter E., Andrade F. Abnormal production of pro- and anti-inflammatory cytokines by lupus monocytes in response to apoptotic cells. PLoS One 2011, 6:e17495.
34. Huynh M.L., Fadok V.A., Henson P.M. Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation. J Clin Invest 2002, 109:41-50.
35. Miwa K., Asano M., Horai R., Iwakura Y., Nagata S., Suda T. Caspase 1-independent IL-1beta release and inflammation induced by the apoptosis inducer Fas ligand. Nat Med 1998, 4:1287-1292.
36. Sansonetti P.J., Phalipon A., Arondel J., Thirumalai K., Banerjee S., Akira S., et al. Caspase-1 activation of IL-1beta and IL-18 are essential for Shigella flexneri-induced inflammation. Immunity 2000, 12:581-590.
37. Schulze C., Munoz L.E., Franz S., Sarter K., Chaurio R.A., Gaipl U.S., et al. Clearance deficiency-a potential link between infections and autoimmunity. Autoimmun Rev 2008, 8:5-8.
38. Cox J.H., Starr A.E., Kappelhoff R., Yan R., Roberts C.R., Overall C.M. Matrix metalloproteinase 8 deficiency in mice exacerbates inflammatory arthritis through delayed neutrophil apoptosis and reduced caspase 11 expression. Arthritis Rheum 2010, 62:3645-3655.
39. Krysko O., Vandenabeele P., Krysko D.V., Bachert C. Impairment of phagocytosis of apoptotic cells and its role in chronic airway diseases. Apoptosis 2010, 15:1137-1146.
40. Suzuki M., Hashizume M., Yoshida H., Mihara M. Anti-inflammatory mechanism of tocilizumab, a humanized anti-IL-6R antibody: effect on the expression of chemokine and adhesion molecule. Rheumatol Int 2010, 30:309-315.
41. Harada H., Kukita T., Kukita A., Iwamoto Y., Iijima T. Involvement of lymphocyte function-associated antigen-1 and intercellular adhesion molecule-1 in osteoclastogenesis: a possible role in direct interaction between osteoclast precursors. Endocrinology 1998, 139:3967-3975.
42. Qi J., Kreutzer D.L., Piela-Smith T.H. Fibrin induction of ICAM-1 expression in human vascular endothelial cells. J Immunol 1997, 158:1880-1886.
43. Parfitt A.M. Osteoclast precursors as leukocytes: importance of the area code. Bone 1998, 23:491-494.
44. May L.T., Viguet H., Kenney J.S., Ida N., Allison A.C., Sehgal P.B. High levels of "complexed" interleukin-6 in human blood. J Biol Chem 1992, 267:19698-19704.
45. Li W., Gardinier J.D., Price C., Wang L. Does blood pressure enhance solute transport in the bone lacunar-canalicular system?. Bone 2010, 47:353-359.